Reports
-
Chagas Disease: Update on progress and future perspectives
This document is intended to provide an overview of American trypanosomiasis or Chagas’ disease. It is meant for both medical and non-medical readers, and seeks to present a comprehensive view on both...
Last updated 3 August 2006
www.msfaccess.org/our-work/addressing-medical-challenges/article/931 -
MSF Human African Trypanosomiasis Dossier
This document provides an overview of present issues surrounding the control of human African trypanosomiasis (HAT), or sleeping sickness, caused by the parasite Trypanosoma brucei gambiense. It is meant...
Last updated 1 July 2006
www.msfaccess.org/our-work/addressing-medical-challenges/article/932 -
Full Prescription: Better Malaria Treatment for More People, MSF's experience
Although effective tools exist to identify and treat malaria – one of the main infectious diseases responsible for high mortality, especially among children in sub-Saharan Africa – Médecins Sans...
Last updated 30 September 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/907 -
The Crisis of Neglected Diseases: Developing Treatments and Ensuring Access - Conference report
Report of the conference held in March 2002 in New York, summarising key issues and findings, including extent of the crisis in R&D for drugs for neglected diseases, possible solutions (PPPs, governmental...
Last updated 12 April 2002
www.msfaccess.org/our-work/addressing-medical-challenges/article/956 -
Access to HIV/AIDS medicines in Thailand
This MSF report to the national AIDS committee of Thailand describes access to HIV/AIDS drugs in Thailand and issues related to TRIPS– including US pressure on Thailand to adopt “TRIPS plus” standards...
Last updated 1 August 1999
www.msfaccess.org/our-work/addressing-medical-challenges/article/959 -
Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS- Spanish version
A joint UNICEF, UNAIDS, WHO and MSF document providing market information to help procurement agencies make informed decisions on the source of drugs and to serve as the basis for negotiating affordable...
Last updated 1 May 2002
www.msfaccess.org/our-work/addressing-medical-challenges/article/955 -
Untangling The Web (10th edition)-English-Update 2
Highlight: · GSK has announced reductions in ARV prices for Least Developed Countries and Sub-Saharan Africa as well as countries with eligible Global Fund and PEPFAR projects. The prices include...
Last updated 4 March 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/914 -
Untangling the Web - 5th Edition
This is the fifth edition of 'Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries', the first edition was published in October 2001.
Last updated 17 December 2003
www.msfaccess.org/our-work/addressing-medical-challenges/article/941 -
Untangling the Web 4th Edition
This is the fourth edition of 'Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries', the first edition was published in October 2001.
Last updated 26 May 2003
www.msfaccess.org/our-work/addressing-medical-challenges/article/949 -
Untangling the Web 3rd Edition
This is the third edition of 'Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries', the first edition was published in October 2001.
Last updated 3 December 2002
www.msfaccess.org/our-work/addressing-medical-challenges/article/953
